R J BIO-TECH | HPC BIOSCIENCES | R J BIO-TECH/ HPC BIOSCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | - | - | - | View Chart |
P/BV | x | - | 12.5 | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
R J BIO-TECH HPC BIOSCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
R J BIO-TECH Mar-22 |
HPC BIOSCIENCES Mar-21 |
R J BIO-TECH/ HPC BIOSCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | NA | - | |
Low | Rs | 5 | NA | - | |
Sales per share (Unadj.) | Rs | 14.7 | 0.1 | 10,245.4% | |
Earnings per share (Unadj.) | Rs | -4.3 | 0.1 | -5,832.4% | |
Cash flow per share (Unadj.) | Rs | -4.2 | 0.1 | -3,989.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | -53.2 | 2.1 | -2,582.5% | |
Shares outstanding (eoy) | m | 9.47 | 159.60 | 5.9% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.6 | 0 | - | |
Avg P/E ratio | x | -2.0 | 0 | - | |
P/CF ratio (eoy) | x | -2.0 | 0 | - | |
Price / Book Value ratio | x | -0.2 | 0 | - | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 81 | 0 | - | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 6 | 1 | 1,178.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 139 | 23 | 607.9% | |
Other income | Rs m | 7 | 1 | 792.9% | |
Total revenues | Rs m | 146 | 24 | 614.6% | |
Gross profit | Rs m | 12 | 16 | 72.0% | |
Depreciation | Rs m | 1 | 5 | 13.1% | |
Interest | Rs m | 58 | 0 | - | |
Profit before tax | Rs m | -40 | 12 | -339.7% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | 0.0% | |
Profit after tax | Rs m | -40 | 12 | -346.1% | |
Gross profit margin | % | 8.4 | 70.8 | 11.8% | |
Effective tax rate | % | 0 | 1.8 | -0.0% | |
Net profit margin | % | -29.1 | 51.2 | -56.9% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 3 | 261 | 1.1% | |
Current liabilities | Rs m | 484 | 3 | 17,268.9% | |
Net working cap to sales | % | -345.9 | 1,128.3 | -30.7% | |
Current ratio | x | 0 | 93.1 | 0.0% | |
Inventory Days | Days | 3 | 637 | 0.4% | |
Debtors Days | Days | 7,265,677 | 910,260,375 | 0.8% | |
Net fixed assets | Rs m | 16 | 71 | 23.1% | |
Share capital | Rs m | 95 | 160 | 59.3% | |
"Free" reserves | Rs m | -598 | 169 | -354.1% | |
Net worth | Rs m | -503 | 329 | -153.2% | |
Long term debt | Rs m | 33 | 0 | - | |
Total assets | Rs m | 19 | 331 | 5.8% | |
Interest coverage | x | 0.3 | 0 | - | |
Debt to equity ratio | x | -0.1 | 0 | - | |
Sales to assets ratio | x | 7.2 | 0.1 | 10,495.5% | |
Return on assets | % | 92.4 | 3.5 | 2,615.9% | |
Return on equity | % | 8.0 | 3.6 | 225.9% | |
Return on capital | % | -3.8 | 3.6 | -103.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 2.5 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 4 | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 4 | 0 | - | |
Net fx | Rs m | -4 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -47 | 14 | -346.8% | |
From Investments | Rs m | NA | 1 | 0.0% | |
From Financial Activity | Rs m | 47 | NA | - | |
Net Cashflow | Rs m | 0 | 14 | -2.7% |
Indian Promoters | % | 60.3 | 21.9 | 275.1% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 39.7 | 78.1 | 50.8% | |
Shareholders | 245 | 648 | 37.8% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare R J BIO-TECH With: KAVERI SEED VENKYS
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | R J BIO-TECH | HPC BIOSCIENCES | S&P BSE FMCG |
---|---|---|---|
1-Day | 0.59% | 0.00% | 2.18% |
1-Month | 1.48% | 0.00% | -4.76% |
1-Year | -26.39% | 0.00% | 9.08% |
3-Year CAGR | -24.59% | -1.29% | 14.03% |
5-Year CAGR | -25.99% | -0.96% | 12.27% |
* Compound Annual Growth Rate
Here are more details on the R J BIO-TECH share price and the HPC BIOSCIENCES share price.
Moving on to shareholding structures...
The promoters of R J BIO-TECH hold a 60.3% stake in the company. In case of HPC BIOSCIENCES the stake stands at 21.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of R J BIO-TECH and the shareholding pattern of HPC BIOSCIENCES.
Finally, a word on dividends...
In the most recent financial year, R J BIO-TECH paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
HPC BIOSCIENCES paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of R J BIO-TECH, and the dividend history of HPC BIOSCIENCES.
For a sector overview, read our fmcg sector report.
After opening the day higher, Indian benchmark indices remained positive as the session progressed and ended the day on firm footing.